Speaking Of Medtech, Ep. 5: MDUFA V User-Fee Negotiations
Executive Summary
In this episode of Speaking Of Medtech we discuss the Medical Device User Fee Amendments, or MDUFA, the negotiations for which come around every five years. The MDUFA V talks between industry and the US FDA appear with the inevitability of an unloved season – it seems no one is ever terribly excited to engage in the user-fee process. Here, we break things down.
You may also be interested in...
Opinion: Getting Work Done in the ’New Normal‘ CDRH
In this op/ed, consultant and former FDA official Steve Silverman reveals how medical device firms can best interact with the US Food and Drug Administration's Center for Devices and Radiological Health as the COVID-19 pandemic recedes.
Opinion: Happy New Year – the Sequel
In this op/ed, consultant and former FDA official Steve Silverman looks at what he got right – and wrong – in his predictions for 2022 and walks us through his expectations for the new year.
Opinion: Digital Health Precertification -- The Little Engine That Couldn’t (Yet)
In this op/ed, former US FDA device compliance chief Steve Silverman argues that while the agency's digital health precertification (Pre-Cert) pilot program failed to make much of a splash, the concept deserves a second look -- and more Congressional support.